TCL Archive Facilities Survey To Include All Institutions With $200,000 Or More in NCI Support October 5, 1984
TCL Archive DCT Board Okays $3 Million In New Programs, $8 Million In Recompetitions October 24, 1980
TCL Archive Tasigna Shows Benefit Over Gleevec In Phase III Study for Ph+ CML In Chronic Phase December 31, 2010
TCL Archive AVEO’s Tivozanib Sunk by Fundamental Flaw: Higher Overall Survival in the Control Arm May 8, 2013
